🔗 Permalink

Inventor profile of:

Michael C. Holmes

City:

Richmond, California

Country:

United States

Published Applications:

Last publication date:

2025-03-27

Top Assignees for applications by Michael C. Holmes

The entities that hold a legal rights for patent applications filed by inventor Holmes Michael C.:

Sangamo Therapeutics, Inc. 21 Richmond, CA United States
SANGAMO BIOSCIENCES, INC. 15 Richmond, CA United States
Sangamo Therapeutics, Inc. 8 Brisbane, CA United States
Ospedale San Raffaele S.R.L. 5 Milan, Italy
BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEMS 1 Austin, TX United States
The Children's Hospital of Philadelphia 1 Philadelphia, PA United States
C/O SANGAMO BIOSCIENCES, INC. 1 Richmond, CA United States
Fondazione Telethon 1 Rome, Italy
Board of Regents of the University of Texas System 1 Austin, TX United States
University of Southern California 1 Los Angeles, CA United States
Board of Regents, The University of Texas System 1 Austin, TX United States

Recent patent applications by Holmes Michael C.

Michael C. Holmes from Richmond, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2025-03-27

US20250099624A1

Human necessities

METHODS AND COMPOSITIONS FOR THE TREATMENT OF RARE DISEASES

#2 | 2020-09-24

US20200297762A1

Human necessities

Methods and compositions for targeted cleavage and recombination

#3 | 2020-09-10

US20200282079A1

Human necessities

Methods and compositions for engineering immunity

#4 | 2019-11-21

US20190352671A1

Chemistry; metallurgy

Method of making and using mammalian liver cells for treating hemophilia or lysosomal storage disorder

#5 | 2019-11-21

US20190352614A1

Chemistry; metallurgy

B-CELL ENGINEERING

#6 | 2019-06-06

US20190167815A1

Human necessities

METHODS AND COMPOSITIONS FOR THE TREATMENT OF RARE DISEASES

#7 | 2019-02-14

US20190046579A1

Human necessities

Targeted disruption of T cell receptor genes using engineered zinc finger protein nucleases

#8 | 2018-11-15

US20180326000A1

Human necessities

Methods and compositions for modulating PD1

#9 | 2018-11-08

US20180319864A1

Chemistry; metallurgy

Methods and compositions for modification of a HLA locus

#10 | 2018-11-01

US20180312826A1

Chemistry; metallurgy

Methods and compositions for gene inactivation

#11 | 2018-08-09

US20180223311A1

Chemistry; metallurgy

Methods and compositions for treatment of a genetic condition

#12 | 2018-08-02

US20180216136A1

Chemistry; metallurgy

Delivery methods and compositions for nuclease-mediated genome engineering

#13 | 2018-08-02

US20180214485A1

Human necessities

Targeted disruption of T cell receptor genes using engineered zinc finger protein nucleases

#14 | 2018-07-05

US20180185516A1

Human necessities

DELIVERY OF TARGET SPECIFIC NUCLEASES

#15 | 2017-11-16

US20170326174A1

Human necessities

Methods and compositions for targeted cleavage and recombination

#16 | 2017-07-13

US20170196992A1

Human necessities

Methods and compositions for engineering immunity

#17 | 2017-07-06

US20170189450A1

Human necessities

Gene correction of SCID-related genes in hematopoietic stem and progenitor cells

#18 | 2017-06-29

US20170183420A1

Chemistry; metallurgy

T cell modifying compounds and uses thereof

#19 | 2016-11-10

US20160326505A1

Chemistry; metallurgy

METHODS AND COMPOSITIONS FOR GENE INACTIVATION

#20 | 2016-08-18

US20160237457A1

Chemistry; metallurgy

Linear donor constructs for targeted integration

#21 | 2016-08-04

US20160220634A1

Human necessities

Methods and compositions for modulating PD1

#22 | 2016-07-28

US20160215298A1

Chemistry; metallurgy

Methods and compositions for increased transgene expression

#23 | 2016-06-23

US20160177290A1

Chemistry; metallurgy

Methods and compostions for targeted genomic deletion

#24 | 2016-02-04

US20160030477A1

Human necessities

Gene correction of SCID-related genes in hematopoietic stem and progenitor cells

#25 | 2016-01-28

US20160022838A1

Human necessities

Methods and compositions for treating hemophilia B

#26 | 2015-11-19

US20150329875A1

Chemistry; metallurgy

Methods and compositions for prevention or treatment of a disease

#27 | 2015-09-24

US20150267223A1

Chemistry; metallurgy

METHODS AND COMPOSITIONS FOR REGULATING HIV INFECTION

#28 | 2015-09-10

US20150252094A1

Chemistry; metallurgy

Methods and compositions for modification of a HLA locus

#29 | 2015-08-27

US20150240263A1

Chemistry; metallurgy

Method of treating factor IX deficiency using nuclease-mediated targeted integration

#30 | 2015-08-13

US20150225727A1

Chemistry; metallurgy

Linear donor constructs for targeted integration

#31 | 2015-06-25

US20150174169A1

Human necessities

Delivery methods and compositions for nuclease-mediated genome engineering in hematopoietic stem cells

#32 | 2015-06-18

US20150164954A1

Human necessities

Targeted disruption of T cell receptor genes using engineered zinc finger protein nucleases

#33 | 2015-04-23

US20150110762A1

Chemistry; metallurgy

Delivery methods and compositions for nuclease-mediated genome engineering

#34 | 2015-04-23

US20150110757A1

Human necessities

Modification of CXCR4 using engineered zinc finger proteins

#35 | 2014-12-18

US20140369980A1

Human necessities

Methods and compositions for targeted cleavage and recombination

#36 | 2014-11-13

US20140335063A1

Chemistry; metallurgy

Delivery methods and compositions for nuclease-mediated genome engineering

#37 | 2014-10-09

US20140301990A1

Human necessities

Targeted disruption of T cell receptor genes using talens

#38 | 2014-07-24

US20140205579A1

Chemistry; metallurgy

METHODS AND COMPOSITIONS FOR ALTERATION OF A CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR (CFTR) GENE

#39 | 2014-07-24

US20140205576A1

Chemistry; metallurgy

METHODS AND COMPOSITIONS FOR INCREASED TRANSGENE EXPRESSION

#40 | 2014-05-22

US20140140969A1

Human necessities

METHODS AND COMPOSITIONS FOR MUSCULAR DYSTROPHIES

#41 | 2014-05-08

US20140127811A1

Chemistry; metallurgy

Methods and compositions for gene inactivation

#42 | 2014-05-01

US20140120622A1

Chemistry; metallurgy

T cell modifying compounds and uses thereof

#43 | 2014-04-03

US20140093913A1

Chemistry; metallurgy

Methods and compositions for treatment of a genetic condition

#44 | 2014-03-27

US20140086885A1

Chemistry; metallurgy

Methods and compositions for targeted cleavage and recombination

#45 | 2014-03-20

US20140080216A1

Chemistry; metallurgy

Methods and compositions for treatment of a genetic condition

#46 | 2014-01-30

US20140030240A1

Human necessities

Methods and compositions for modulating PD1

#47 | 2013-09-19

US20130244332A1

Chemistry; metallurgy

Targeted integration and expression on exogenous nucleic acid sequences

#48 | 2013-07-04

US20130171657A1

Chemistry; metallurgy

Rapid screening of biologically active nucleases and isolation of nuclease-modified cells

#49 | 2013-06-06

US20130145485A1

Chemistry; metallurgy

Methods and compositions for alteration of a cystic fibrosis transmembrane conductance regulator (CFTR) gene

#50 | 2012-12-06

US20120308528A1

Chemistry; metallurgy

Methods and compositions for gene inactivation

InventorID:

324328 ⎘